Last week, readers were most interested in Labcorp's acquisition of assets from MAWD, a CE mark for Roche's mass spec system, and features on Volition and Siemens Healthineers.

The companies said they plan to explore a range of questions including the clinical implementation of the Alzheimer's disease biomarker phosphorylated tau 217.

Consolidation within the industry also remained brisk as cost and reimbursement concerns provided acquisition opportunities for large national outfits.

Top Five Articles on 360Dx Last Week: Labcorp Asset Acquisition, Roche CE Mark for Mass Spec, More Last week, readers were most interested in Labcorp's acquisition of assets from MAWD, a CE mark for ...

Only 20 full-company mergers or acquisitions occurred throughout the year, although asset acquisition deals were more common.

Under the agreement, Labcorp will manage Graves Gilbert's main full-service laboratory in Bowling Green, Kentucky and its facility in Glasgow, Kentucky.

The firm also has plans for tests beyond sepsis, including for cardiac events and other conditions that are commonly treated in acute care settings. Becton Dickinson's HPV assay was FDA-approved for ...